Clinical Trial Update: Cardiovascular Improvements With MV ASV Therapy in Heart Failure [NA]

View source ↗

Summary

A trial evaluating MV ASV therapy in heart failure was terminated, with results posted in 2018 showing cardiovascular improvements.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sleep-disordered Breathing

Snippet

Sponsor: ResMed | Conditions: Acute Decompensated Heart Failure, Sleep Disordered Breathing | NA | Status: TERMINATED | Results posted: 2018-02-28